Fresh Funds For Trials Of Novartis’s Novel Malaria Combo In Africa
Executive Summary
New funding has been provided for more trials of Novartis’s combination malaria treatment in west and central Africa, adding to ongoing efforts to tackle the disease on the continent.
You may also be interested in...
Landmark Malaria Vaccine Pilot Launches In Malawi
The first ever malaria vaccine is being launched in three African countries in an effort to gather more evidence about how it should be used in real life settings.
Novartis Starts 'Complex' Trial of Novel Malaria Therapy
A Phase IIb study of Novartis's first-in-class malaria treatment will take in African and Asian sites, patients of all ages, and include a single-dose arm.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.